ibi110
innovent biologics
['ibi110']
sfbn feed: innovent presents clinical data of ibi110 (anti-lag-3 monoclonal antibody) at the 2022 american society of clinical oncology (asco) annual meeting: san francisco and suzhou, china, june 5, 2022 ... #bayarea #biotech 
San Francisco Biotechnology News and Events, follow jobs at @sfbnjobs